{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:05:37Z","timestamp":1793329537081,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan","award":["110441"],"award-info":[{"award-number":["110441"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Recently, ribavirin has been suggested as a therapeutic approach in Crimean\u2013Congo haemorrhagic fever (CCHF) patients; however, there are controversial findings about its efficacy. In the current study, a meta-analysis was systematically performed to assess the effectiveness of ribavirin administration regarding CCHF patient survival and to explore the most important influential parameters for its efficacy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>All of the outcomes of the clinically studied CCHF patients who were treated with ribavirin were included in the meta-analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 24 studies met our criteria. Although the studies did not have high quality there was no heterogeneity and publication bias across studies. The results indicated that the administration of ribavirin to CCHF patients significantly decreased the mortality rate (by 1.7-fold) compared with those who did not receive this medication. Furthermore, it was found that the prescription of ribavirin in the initial phase of disease was more effective, and a delay in the start of treatment resulted in a 1.6-fold increase in mortality rate. In addition, interventional therapy resulted in an \u223c2.3-fold reduction in the mortality rate of those who received ribavirin along with corticosteroids compared with those who were treated with ribavirin monotherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This meta-analysis reveals that ribavirin should be considered as a crucial antiviral drug in the therapeutic approach used for CCHF patients, especially in early phases of the disease. Additionally, it seems that the administration of corticosteroids alongside ribavirin can play an effective role in alleviation of the disease status, particularly in haemorrhagic phases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkz328","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T15:07:28Z","timestamp":1562425648000},"page":"3432-3439","source":"Crossref","is-referenced-by-count":32,"title":["Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean\u2013Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"74","author":[{"given":"Zahra","family":"Arab-Bafrani","sequence":"first","affiliation":[{"name":"Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran"},{"name":"Department of Biochemistry and Biophysics, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jabbari","sequence":"additional","affiliation":[{"name":"Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran"},{"name":"Department of Anesthesiology and Critical Care Medicine, Golestan University of Medical Sciences, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mostakhdem Hashemi","sequence":"additional","affiliation":[{"name":"Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Mohammad","family":"Arabzadeh","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atena","family":"Gilanipour","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Mousavi","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"2019111507201442400_dkz328-B1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","article-title":"Crimean\u2013Congo hemorrhagic fever","volume":"64","author":"Whitehouse","year":"2004","journal-title":"Antiviral Res"},{"key":"2019111507201442400_dkz328-B2","first-page":"204","article-title":"Crimean-Congo hemorrhagic fever","volume":"10","author":"Mardani","year":"2007","journal-title":"Arch Iran Med"},{"key":"2019111507201442400_dkz328-B3","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3201\/eid1008.030928","article-title":"Crimean\u2013Congo hemorrhagic fever in Turkey","volume":"10","author":"Karti","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"2019111507201442400_dkz328-B4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/S0950268800052687","article-title":"Investigation of tick-borne viruses as pathogens of humans in South Africa and evidence of Dugbe virus infection in a patient with prolonged thrombocytopenia","volume":"116","author":"Burt","year":"1996","journal-title":"Epidemiol Infect"},{"key":"2019111507201442400_dkz328-B5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1099\/0022-1317-55-1-165","article-title":"Structural characteristics of nairoviruses (genus Nairovirus, Bunyaviridae)","volume":"55","author":"Clerx","year":"1981","journal-title":"J Gen Virol"},{"key":"2019111507201442400_dkz328-B6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4269\/ajtmh.1970.19.846","article-title":"Congo virus from domestic livestock, African hedgehog, and arthropods in Nigeria","volume":"19","author":"Causey","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"2019111507201442400_dkz328-B7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4269\/ajtmh.1985.34.1179","article-title":"Characteristics of Crimean-Congo hemorrhagic fever virus (Xinjiang strain) in China","volume":"34","author":"Yu-Chen","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"2019111507201442400_dkz328-B8","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0035-9203(87)90379-8","article-title":"Field and laboratory investigation of Crimean-Congo haemorrhagic fever virus (Nairovirus, family Bunyaviridae) infection in birds","volume":"81","author":"Shepherd","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2019111507201442400_dkz328-B9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jmedent\/15.4.307","article-title":"The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa","volume":"15","author":"Hoogstraal","year":"1979","journal-title":"J Med Entomol"},{"key":"2019111507201442400_dkz328-B10","doi-asserted-by":"crossref","first-page":"207.","DOI":"10.1186\/1471-2334-10-207","article-title":"Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis","volume":"10","author":"Soares-Weiser","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2019111507201442400_dkz328-B11","first-page":"CD012713","article-title":"Ribavirin for treating Crimean Congo haemorrhagic fever","author":"Johnson","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2019111507201442400_dkz328-B12","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1016\/j.vaccine.2017.05.031","article-title":"Development of vaccines against Crimean-Congo haemorrhagic fever virus","volume":"35","author":"Dowall","year":"2017","journal-title":"Vaccine"},{"key":"2019111507201442400_dkz328-B13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/vbz.2011.0896","article-title":"Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever","volume":"12","author":"Leblebicioglu","year":"2012","journal-title":"Vector Borne Zoonotic Dis"},{"key":"2019111507201442400_dkz328-B14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2015.12.003","article-title":"Crimean-Congo hemorrhagic fever in Turkey: current status and future challenges","volume":"126","author":"Leblebicioglu","year":"2016","journal-title":"Antiviral Res"},{"key":"2019111507201442400_dkz328-B15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coviro.2013.03.001","article-title":"Intervention strategies for emerging viruses: use of antivirals","volume":"3","author":"Debing","year":"2013","journal-title":"Curr Opin Virol"},{"key":"2019111507201442400_dkz328-B16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4269\/ajtmh.1989.41.581","article-title":"Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin","volume":"41","author":"Watts","year":"1989","journal-title":"Am J Trop Med Hyg"},{"key":"2019111507201442400_dkz328-B17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-3542(93)90040-P","article-title":"Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection","volume":"22","author":"Tignor","year":"1993","journal-title":"Antiviral Res"},{"key":"2019111507201442400_dkz328-B18","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model","volume":"84","author":"Bente","year":"2010","journal-title":"J Virol"},{"key":"2019111507201442400_dkz328-B19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(95)91323-8","article-title":"Crimean Congo-haemorrhagic fever treated with oral ribavirin","volume":"346","author":"Fisher-Hoch","year":"1995","journal-title":"Lancet"},{"key":"2019111507201442400_dkz328-B20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/375058","article-title":"The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran","volume":"36","author":"Mardani","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2019111507201442400_dkz328-B21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1086\/422000","article-title":"Characteristics of patients with Crimean\u2013Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy","volume":"39","author":"Ergonul","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2019111507201442400_dkz328-B22","doi-asserted-by":"crossref","first-page":"387.e1","DOI":"10.1016\/j.cmi.2015.11.024","article-title":"Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002\u20132014: a multicentre retrospective cross-sectional study","volume":"22","author":"Leblebicioglu","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2019111507201442400_dkz328-B23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1179\/1973947813Y.0000000123","article-title":"Do we really need ribavirin in the treatment of Crimean-Congo hemorrhagic fever?","volume":"26","author":"Kal\u0131n","year":"2014","journal-title":"J Chemother"},{"key":"2019111507201442400_dkz328-B24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/cid\/cit527","article-title":"Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality","volume":"57","author":"Dokuzoguz","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019111507201442400_dkz328-B25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1089\/vbz.2013.1421","article-title":"Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever","volume":"14","author":"Ozbey","year":"2014","journal-title":"Vector Borne Zoonotic Dis"},{"key":"2019111507201442400_dkz328-B26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4103\/0019-5359.26609","article-title":"Crimean-Congo hemorrhagic fever: case series from a medical center in Golestan province, Northeast of Iran (2004\u20132006)","volume":"60","author":"Jabbari","year":"2006","journal-title":"Indian J Med Sci"},{"key":"2019111507201442400_dkz328-B27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0049475513486642","article-title":"Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia","volume":"43","author":"Sharifi-Mood","year":"2013","journal-title":"Trop Doct"},{"key":"2019111507201442400_dkz328-B28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jac\/dkr136","article-title":"Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis","volume":"66","author":"Ascioglu","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2019111507201442400_dkz328-B29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1164","article-title":"Methods to estimate the between-study variance and its uncertainty in meta-analysis","volume":"7","author":"Veroniki","year":"2016","journal-title":"Res Synth Methods"},{"key":"2019111507201442400_dkz328-B30","doi-asserted-by":"crossref","first-page":"16983.","DOI":"10.1038\/srep16983","article-title":"Goodness-of-fit test for meta-analysis","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"2019111507201442400_dkz328-B31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/9780470743386.ch7","article-title":"Converting among effect sizes","author":"Borenstein","year":"2009","journal-title":"Introduction to Meta-Analysis"},{"key":"2019111507201442400_dkz328-B32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1198\/sbr.2009.0067","article-title":"Measuring study-specific heterogeneity in meta-analysis: application to an antecedent biomarker study of Alzheimer\u2019s disease","volume":"2","author":"Xiong","year":"2010","journal-title":"Stat Biopharm Res"},{"key":"2019111507201442400_dkz328-B33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2019111507201442400_dkz328-B34","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"2019111507201442400_dkz328-B35","year":"2015"},{"key":"2019111507201442400_dkz328-B36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev Med Virol"},{"key":"2019111507201442400_dkz328-B37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3201\/eid2003.131353","article-title":"Crimean-Congo hemorrhagic fever among health care workers, Turkey","volume":"20","author":"Celikbas","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2019111507201442400_dkz328-B38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"Ergonul","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"2019111507201442400_dkz328-B39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10096-009-0728-2","article-title":"The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising","volume":"28","author":"Tasdelen Fisgin","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019111507201442400_dkz328-B40","first-page":"201","article-title":"Ribavirin: an effective treatment of Crimean-Congo haemorrhagic fever","volume":"20","author":"Sheikh","year":"2004","journal-title":"Pakistan J Med Sci"},{"key":"2019111507201442400_dkz328-B41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jinf.2007.05.179","article-title":"New insights on the bleeding disorders in CCHF","volume":"55","author":"Doganci","year":"2007","journal-title":"J Infect"},{"key":"2019111507201442400_dkz328-B42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.20969","article-title":"Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome","volume":"83","author":"Fisgin","year":"2008","journal-title":"Am J Hematol"},{"key":"2019111507201442400_dkz328-B43","first-page":"23","article-title":"An effective treatment strategy for cytokine storm in severe influenza","volume":"49","author":"Murphy","year":"2017","journal-title":"Am Lab"},{"key":"2019111507201442400_dkz328-B44","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.ijid.2010.09.009","article-title":"Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever","volume":"15","author":"Bodur","year":"2011","journal-title":"Int J Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/12\/3432\/30795234\/dkz328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/12\/3432\/30795234\/dkz328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T07:20:29Z","timestamp":1573802429000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/12\/3432\/5542609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,8,1]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz328","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,8,1]]}}}